Ingrid Øra

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. pmc Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
    Fieke Lamers
    Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, Amsterdam, AZ 1105, The Netherlands
    BMC Cancer 12:285. 2012
  2. doi request reprint Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research
    Ingrid Øra
    Department of Pediatric Oncology and Hematology, Skane University Hospital, Lund University, Lund, Sweden
    Semin Cancer Biol 21:217-28. 2011

Collaborators

  • Fieke Lamers
  • Ellen M Westerhout
  • Linda Schild
  • Jan J Molenaar
  • Frank Speleman
  • Huib N Caron
  • Rogier Versteeg
  • Peter van Sluis
  • Jan Koster

Detail Information

Publications2

  1. pmc Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
    Fieke Lamers
    Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, Amsterdam, AZ 1105, The Netherlands
    BMC Cancer 12:285. 2012
    ..Neuroblastoma are pediatric tumors of the sympathetic nervous system with a poor prognosis. Apoptosis is often deregulated in cancer cells, but only a few defects in apoptotic routes have been identified in neuroblastoma...
  2. doi request reprint Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research
    Ingrid Øra
    Department of Pediatric Oncology and Hematology, Skane University Hospital, Lund University, Lund, Sweden
    Semin Cancer Biol 21:217-28. 2011
    ..This review describes the current efforts and trends in neuroblastoma research from a clinical perspective in order to highlight the urgent clinical problems we must address together with basic researchers...